Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survival.

Prem S, Atenafu EG, Lam W, Law A, Michelis FV, Kim D, Viswabandya A, Howard Lipton J, Mattsson J, Kumar R.

Eur J Haematol. 2019 Nov 18. doi: 10.1111/ejh.13353. [Epub ahead of print]

PMID:
31737967
2.

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

El-Serafi I, Remberger M, Ringdèn O, Törlén J, Sundin M, Björklund A, Winiarski J, Mattsson J.

Clin Transl Sci. 2019 Nov 1. doi: 10.1111/cts.12709. [Epub ahead of print]

PMID:
31675173
3.

The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity.

Magalhaes I, Yogev O, Mattsson J, Schurich A.

Front Immunol. 2019 Oct 4;10:2309. doi: 10.3389/fimmu.2019.02309. eCollection 2019. Review.

4.

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.

Salas MQ, Atenafu EG, Bautista MR, Prem S, Lam W, Datt Law A, Shaibani ZA, Kim DDH, Michelis FV, Lipton JH, Viswabandya A, Mattsson J, Kumar R.

Eur J Haematol. 2019 Sep 23. doi: 10.1111/ejh.13332. [Epub ahead of print]

PMID:
31549435
5.

Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.

Salas MQ, Lam W, Law AD, Kim DDH, Michelis FV, Loach D, Al-Shaibani Z, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Dec;103(6):597-606. doi: 10.1111/ejh.13327. Epub 2019 Sep 30.

PMID:
31514253
6.

Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trial.

Corderfeldt A, Nielsen S, Katsarelias D, Hjärpe A, Mattsson J, Olofsson Bagge R.

Int J Hyperthermia. 2019;36(1):794-800. doi: 10.1080/02656736.2019.1640900.

PMID:
31450986
7.

Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

Salas MQ, Prem S, Atenafu EG, Law AD, Lam W, Al-Shaibani Z, Loach D, Kim DDH, Michelis FV, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Nov;103(5):510-518. doi: 10.1111/ejh.13321. Epub 2019 Sep 9.

PMID:
31449699
8.

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.

Prem S, Atenafu EG, Avena J, Bautista R, Law A, Lam W, Michelis FV, Kim DDH, Viswabandya A, Lipton JH, Mattsson J, Kumar R.

Eur J Haematol. 2019 Nov;103(5):483-490. doi: 10.1111/ejh.13314. Epub 2019 Sep 5.

PMID:
31418930
9.

Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation.

Berglund S, Watz E, Remberger M, Garming Legert K, Axdorph-Nygell U, Sundin M, Uhlin M, Mattsson J.

Vox Sang. 2019 Oct;114(7):769-777. doi: 10.1111/vox.12835. Epub 2019 Aug 11.

PMID:
31402469
10.

Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.

Prem S, Al-Shaibani Z, Michelis FV, Kim D, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Law A, Lam W.

Eur J Haematol. 2019 Nov;103(5):519-522. doi: 10.1111/ejh.13309. Epub 2019 Aug 27.

PMID:
31389104
11.
12.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

13.

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.

Tsakonas G, Botling J, Micke P, Rivard C, LaFleur L, Mattsson J, Boyle T, Hirsch FR, Ekman S.

Lung Cancer. 2019 Jul;133:69-74. doi: 10.1016/j.lungcan.2019.04.028. Epub 2019 May 1.

PMID:
31200831
14.

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.

Sadeghi B, Remberger M, Gustafsson B, Winiarski J, Moretti G, Khoein B, Klingspor L, Westgren M, Mattsson J, Ringdén O.

Biol Blood Marrow Transplant. 2019 Oct;25(10):1965-1969. doi: 10.1016/j.bbmt.2019.05.034. Epub 2019 Jun 4.

PMID:
31173898
15.

Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.

Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1761-1769. doi: 10.1016/j.bbmt.2019.05.029. Epub 2019 Jun 4.

PMID:
31170520
16.

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.

Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hägglund H, Mattsson J, Uhlin M.

Cent Eur J Immunol. 2019;44(1):84-91. doi: 10.5114/ceji.2018.75831. Epub 2019 Apr 15.

17.

BRAF status as a predictive factor for response in isolated limb perfusion.

Belgrano V, Mattsson J, Nilsson J, Olofsson Bagge R, Katsarelias D.

Int J Hyperthermia. 2019;36(1):511-515. doi: 10.1080/02656736.2019.1601778. Epub 2019 Apr 15.

PMID:
30987478
18.

Facing the future: challenges and opportunities in adoptive T cell therapy in cancer.

Magalhaes I, Carvalho-Queiroz C, Hartana CA, Kaiser A, Lukic A, Mints M, Nilsson O, Grönlund H, Mattsson J, Berglund S.

Expert Opin Biol Ther. 2019 Aug;19(8):811-827. doi: 10.1080/14712598.2019.1608179. Epub 2019 Apr 30.

PMID:
30986360
19.

Leakage through the bone-marrow during isolated limb perfusion in the lower extremity.

Katsarelias D, Båth J, Carlson P, Mattsson J, Olofsson Bagge R.

J Surg Case Rep. 2019 Apr 3;2019(4):rjz090. doi: 10.1093/jscr/rjz090. eCollection 2019 Apr.

20.

A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease.

Csanadi M, Agh T, Tordai A, Webb T, Jeyakumaran D, Sengupta N, Schain F, Mattsson J.

Expert Rev Hematol. 2019 May;12(5):311-323. doi: 10.1080/17474086.2019.1605288. Epub 2019 Apr 19.

PMID:
30955381
21.

Programmed Cell Death Ligand 1 Immunohistochemistry: A Concordance Study Between Surgical Specimen, Biopsy, and Tissue Microarray.

Elfving H, Mattsson JSM, Lindskog C, Backman M, Menzel U, Micke P.

Clin Lung Cancer. 2019 Jul;20(4):258-262.e1. doi: 10.1016/j.cllc.2019.02.012. Epub 2019 Feb 27.

PMID:
30926355
22.

Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status.

Agh T, Csanadi M, Voko Z, Webb T, Jeyakumaran D, Trudeau J, Sengupta N, Schain F, Mattsson J.

Expert Rev Hematol. 2019 May;12(5):295-309. doi: 10.1080/17474086.2019.1602036. Epub 2019 Apr 14.

PMID:
30925855
23.

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.

La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson J, Brunnström H, Nilsson M, Micke P, Moens L, Botling J.

Lung Cancer. 2019 Apr;130:50-58. doi: 10.1016/j.lungcan.2019.01.003. Epub 2019 Jan 9.

24.

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.

Svenberg P, Wang T, Uhlin M, Watz E, Remberger M, Ringden O, Mattsson J, Uzunel M.

Clin Transplant. 2019 Jun;33(6):e13537. doi: 10.1111/ctr.13537. Epub 2019 May 7.

PMID:
30873642
25.

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.

Rådestad E, Sundin M, Törlén J, Thunberg S, Önfelt B, Ljungman P, Watz E, Mattsson J, Uhlin M.

Front Immunol. 2019 Feb 11;10:189. doi: 10.3389/fimmu.2019.00189. eCollection 2019.

26.

Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.

Nakajima A, Taniguchi S, Kurosu S, Gillberg PG, Mattsson JP, Camilleri M.

Neurogastroenterol Motil. 2019 May;31(5):e13571. doi: 10.1111/nmo.13571. Epub 2019 Feb 21.

27.

T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.

Gaballa A, Stikvoort A, Önfelt B, Mattsson J, Sundin M, Watz E, Uhlin M.

Bone Marrow Transplant. 2019 Oct;54(10):1562-1574. doi: 10.1038/s41409-019-0462-z. Epub 2019 Feb 5.

PMID:
30723262
28.

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.

Micke P, Botling J, Mattsson JSM, Planck M, Tran L, Vidarsdottir H, Nodin B, Jirström K, Brunnström H.

Sci Rep. 2019 Feb 4;9(1):1319. doi: 10.1038/s41598-018-37722-0.

29.

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Törlén J, Gaballa A, Remberger M, Mörk LM, Sundberg B, Mattsson J, Uhlin M.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1260-1268. doi: 10.1016/j.bbmt.2019.01.029. Epub 2019 Jan 30.

30.

Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors.

Schurich A, Magalhaes I, Mattsson J.

Immunotherapy. 2019 Mar;11(4):335-345. doi: 10.2217/imt-2018-0141.

31.

Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.

Edlund K, Madjar K, Mattsson JSM, Djureinovic D, Lindskog C, Brunnström H, Koyi H, Brandén E, Jirström K, Pontén F, Rahnenführer J, Micke P, Hengstler JG.

J Thorac Oncol. 2019 Apr;14(4):628-640. doi: 10.1016/j.jtho.2018.12.022. Epub 2019 Jan 9.

32.

Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma.

Belgrano V, Pettersson J, Nilsson JA, Mattsson J, Katsarelias D, Olofsson Bagge R.

Ann Surg Oncol. 2019 Apr;26(4):1055-1062. doi: 10.1245/s10434-018-07143-4. Epub 2019 Jan 7.

33.

Pre-formulation investigations for establishing a protocol for treosulfan handling and activation.

El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J.

Pharm Dev Technol. 2019 Jun;24(5):639-648. doi: 10.1080/10837450.2018.1551903. Epub 2019 Jan 10.

34.

Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review.

Fløisand Y, Lazarevic VL, Maertens J, Mattsson J, Shah NN, Zachée P, Taylor A, Akbari M, Quadri S, Parfionovas A, Chen YB.

Biol Blood Marrow Transplant. 2019 Apr;25(4):720-727. doi: 10.1016/j.bbmt.2018.11.013. Epub 2018 Nov 22.

35.

Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.

Djureinovic D, Dodig-Crnković T, Hellström C, Holgersson G, Bergqvist M, Mattsson JSM, Pontén F, Ståhle E, Schwenk JM, Micke P.

Lung Cancer. 2018 Nov;125:157-163. doi: 10.1016/j.lungcan.2018.09.012. Epub 2018 Sep 17.

PMID:
30429015
36.

Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignancies.

Olofsson Bagge R, Carlson P, Razzazian R, Hansson C, Hjärpe A, Mattsson J, Katsarelias D.

Int J Hyperthermia. 2018;35(1):667-673. doi: 10.1080/02656736.2018.1522000. Epub 2018 Nov 14.

PMID:
30428725
37.

Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.

Belgrano V, Katsarelias D, Mattsson J, Olofsson Bagge R.

Eur J Surg Oncol. 2019 Feb;45(2):225-230. doi: 10.1016/j.ejso.2018.08.031. Epub 2018 Oct 19.

PMID:
30391091
38.

Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.

Vidarsdottir H, Tran L, Nodin B, Jirström K, Planck M, Jönsson P, Mattsson JSM, Botling J, Micke P, Brunnström H.

Hum Pathol. 2019 Feb;84:221-230. doi: 10.1016/j.humpath.2018.10.009. Epub 2018 Oct 31.

PMID:
30389437
39.

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor.

Ringden O, Remberger M, Gustafsson B, Moretti G, Mattsson J, Winiarski J, Sadeghi B.

Transplantation. 2019 Jun;103(6):1247-1252. doi: 10.1097/TP.0000000000002481.

PMID:
30300286
40.

Facilitating affective elements in learning - In a palliative care context.

Kangas-Niemi A, Manninen K, Mattsson J.

Nurse Educ Pract. 2018 Nov;33:148-153. doi: 10.1016/j.nepr.2018.09.007. Epub 2018 Oct 3.

PMID:
30296727
41.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Emruli VK, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M.

NPJ Precis Oncol. 2018 Sep 3;2:18. doi: 10.1038/s41698-018-0061-2. eCollection 2018.

42.

Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.

Vidarsdottir H, Tran L, Nodin B, Jirström K, Planck M, Mattsson JSM, Botling J, Micke P, Jönsson P, Brunnström H.

Am J Clin Pathol. 2018 Oct 24;150(6):533-544. doi: 10.1093/ajcp/aqy083.

PMID:
30169783
43.

Operating Room Nurses' Perceptions of the Clinical Learning Environment: A Survey Study.

Crafoord MT, Mattsson J, Fagerdahl AM.

J Contin Educ Nurs. 2018 Sep 1;49(9):416-423. doi: 10.3928/00220124-20180813-07.

PMID:
30148539
44.

Nanoscale mechanics of microgel particles.

Aufderhorst-Roberts A, Baker D, Foster RJ, Cayre O, Mattsson J, Connell SD.

Nanoscale. 2018 Aug 30;10(34):16050-16061. doi: 10.1039/c8nr02911c.

45.

An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.

Horie M, Miyashita N, Mattsson JSM, Mikami Y, Sandelin M, Brunnström H, Micke P, Nagase T, Saito A.

J Pathol. 2018 Oct;246(2):154-165. doi: 10.1002/path.5109. Epub 2018 Aug 13.

PMID:
29876935
46.

Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells.

Alnabhan R, Gaballa A, Mörk LM, Mattsson J, Uhlin M, Magalhaes I.

Cytotherapy. 2018 Jul;20(7):941-951. doi: 10.1016/j.jcyt.2018.04.007. Epub 2018 May 30.

PMID:
29859774
47.

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation.

El-Serafi I, Remberger M, El-Serafi A, Benkessou F, Zheng W, Martell E, Ljungman P, Mattsson J, Hassan M.

Sci Rep. 2018 May 29;8(1):8293. doi: 10.1038/s41598-018-26033-z.

48.

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.

Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):537-547. doi: 10.1016/S2468-1253(18)30123-7. Epub 2018 May 25.

PMID:
29805116
49.

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Katsarelias D, Rådbo E, Ben-Shabat I, Mattsson J, Olofsson Bagge R.

Ann Surg Oncol. 2018 Jul;25(7):1836-1842. doi: 10.1245/s10434-018-6459-9. Epub 2018 May 15.

50.

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

La Fleur L, Boura VF, Alexeyenko A, Berglund A, Pontén V, Mattsson JSM, Djureinovic D, Persson J, Brunnström H, Isaksson J, Brandén E, Koyi H, Micke P, Karlsson MCI, Botling J.

Int J Cancer. 2018 Oct 1;143(7):1741-1752. doi: 10.1002/ijc.31545. Epub 2018 May 13.

Supplemental Content

Loading ...
Support Center